SEC Filings
Xencor Posts $39.4 Million Quarterly Profit As Revenue Hits $116.5 Million, Up From $21.0 Million
Royalties from Alexion and Incyte and an Astellas milestone drove the swing from a year-earlier loss; nine-month results are still a loss.
Xencor (XNCR) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
SEC Filings
Royalties from Alexion and Incyte and an Astellas milestone drove the swing from a year-earlier loss; nine-month results are still a loss.
SEC Filings
Alexion has paid $52.5 million of the settlement, so receivables jumped to $64.8 million and nine-month operating cash flow was negative $120.6 million.
SEC Filings
The company plans FDA talks on an accelerated approval path and a head-to-head trial against tivozanib, with cash it expects to last into 2029.